Pathogenic Escherichia coli: Virulence Mechanism and Antimicrobial Resistance
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Genetic and Biochemical Studies of Antibiotic Activity and Resistance".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 1421
Special Issue Editor
Interests: antibiotic resistance genes; epidemiology; infectious diseases; antibiotic resistance mechanisms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Escherichia coli is a bacterium that causes serious infections in humans and animals, and it also represents an important part of the autochthonous microbiota of different hosts. It is naturally susceptible to almost all clinically relevant antimicrobial agents; however, this bacterial species has a high capacity to accumulate resistance genes, mainly through horizontal gene transfer. In addition, there are several highly adapted E. coli clones that have acquired specific virulence attributes, giving them an enhanced ability to adapt to new niches and allowing them to cause a broad spectrum of disease. Transmission of virulent and/or resistant E. coli between animals and humans is also a major concern.
Therefore, pathogenic E. coli are considered a real public health problem and are one of the major challenges for humans and animals worldwide.
Dr. Linda Hadjadj
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Escherichia coli
- infectious diseases
- antibiotic resistance
- virulence
- epidemiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
